APYX - Apyx Medical Corporation
| Previous Close | 7.53 |
| Open | 7.56 |
| Bid | 7.58 x 2900 |
| Ask | 7.59 x 800 |
| Day's Range | 7.48 - 7.67 |
| 52 Week Range | 3.55 - 8.89 |
| Volume | 85,662 |
| Avg. Volume | 158,633 |
| Market Cap | 256.107M |
| Beta (3Y Monthly) | 0.32 |
| PE Ratio (TTM) | 4.50 |
| EPS (TTM) | 1.68 |
| Earnings Date | Oct 30, 2019 - Nov 4, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9.25 |
-
Simply Wall St.
What Kind Of Investor Owns Most Of Apyx Medical Corporation (NASDAQ:APYX)?
A look at the shareholders of Apyx Medical Corporation (NASDAQ:APYX) can tell us which group is most powerful...
-
Business Wire
Shareholder Alert: Robbins Arroyo LLP Reminds Investors Apyx Medical Corporation (APYX) Sued for Misleading Shareholders
Shareholder rights law firm Robbins Arroyo LLP reminds investors that a purchaser of Apyx Medical Corporation filed a class action complaint for alleged violations of the Securities Exchange Act of 1934 between August 1, 2018 and April 1, 2019.
-
Business Wire
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in September and October
A live audio webcast of the presentation at the Cantor Fitzgerald Global Healthcare Conference will be provided under the ‘Company Events’ section of the Apyx Medical Corporation investor relations website at https://apyxmedical.com/investor_relations/. An archive of the webcast will be available for replay following the conferences.
-
Motley FoolApyx Medical Corp (APYX) Q2 2019 Earnings Call Transcript
APYX earnings call for the period ending June 30, 2019.
-
Zacks
Apyx Medical (APYX) Reports Q2 Loss, Tops Revenue Estimates
Apyx (APYX) delivered earnings and revenue surprises of 27.78% and 7.67%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
-
Business Wire
Apyx Medical Corporation Reports Second Quarter and First Half of 2019 Financial Results and Updates Fiscal Year 2019 Outlook
Advanced Energy Sales of $5.3 million in Q2, up 69% year-over-year
-
Business Wire
Apyx Medical Corporation Announces Appointment of Minnie Baylor-Henry to the Company’s Board of Directors
Apyx Medical Corporation, formerly Bovie Medical Corporation, (APYX) (the “Company”), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announced today that the Company has appointed Minnie Baylor-Henry to the Board of Directors, effective August 1, 2019. Ms. Baylor-Henry will serve as a Director and as Chair of the newly-created Regulatory and Compliance Committee. “Ms. Baylor-Henry is an accomplished professional in the healthcare industry with over 20 years of experience in Regulatory Affairs, including leadership positions at both large global medical device companies and the U.S. Food & Drug Administration,” said Charlie Goodwin, Chief Executive Officer.
-
Business Wire
Apyx Medical Corporation Receives 510(k) Clearance for Next-Generation J-Plasma® Precise Handpiece Designed for Laparoscopic Surgery
Apyx Medical Corporation, formerly Bovie Medical Corporation, (APYX) (the “Company”), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announced today that it received U.S. Food and Drug Administration (FDA) 510(k) clearance to market and sell its next-generation J-Plasma Precise Handpiece. The Company’s J-Plasma handpieces are indicated for cutting, coagulation and ablation of soft tissue during open and laparoscopic surgical procedures. The original and next-generation of this J-Plasma Precise Handpiece is designed specifically for use in laparoscopic surgical procedures.
-
Zacks
Earnings Preview: Apyx Medical (APYX) Q2 Earnings Expected to Decline
Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
-
Simply Wall St.
Apyx Medical (NASDAQ:APYX) May Be Weighed Down By Its Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
-
Insider Monkey
Hedge Funds Have Never Been This Bullish On Apyx Medical Corporation (APYX)
Before we spend days researching a stock idea we like to take a look at how hedge funds and billionaire investors recently traded that stock. The S&P 500 Index ETF (SPY) lost 2.6% in the first two months of the second quarter. Ten out of 11 industry groups in the S&P 500 Index lost value […]
-
Business Wire
MONDAY DEADLINE NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Apyx Medical Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Apyx Medical Corporation (“Apyx” or “the Company”) (NASDAQ: APYX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
-
GlobeNewswire
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of APYX, NOK, HRTX and TUSK
NEW YORK, June 17, 2019 -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a.
-
GlobeNewswire
MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Apyx Medical Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Apyx Medical Corporation (“Apyx” or “the Company”) (NASDAQ: APYX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The clinical study of Apyx’s J-Plasma for dermal resurfacing did not reach its primary efficacy endpoint.
-
ACCESSWIRE
TOP RANKED ROSEN LAW FIRM REMINDS: Apyx Medical Investors of JUNE 17 DEADLINE IN CLASS ACTION - APYX
NEW YORK, NY / ACCESSWIRE / June 16, 2019 / Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Apyx Medical Corporation (NASDAQ: APYX) from August 1, 2018 through ...
-
Business Wire
MONDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Apyx Medical Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Apyx Medical Corporation (“Apyx” or “the Company”) (NASDAQ: APYX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
-
GlobeNewswire
CLASS ACTION UPDATE for WSR, APYX, KSHB and CYH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, June 14, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
-
ACCESSWIRE
SHAREHOLDER ALERT: FSNN APYX CYH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / June 14, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have ...
-
GlobeNewswire
INVESTOR ALERT: Kaskela Law LLC Announces Important Shareholder Class Action Lawsuit Deadlines – APYX, WSR and INVVY
PHILADELPHIA, June 13, 2019 -- Kaskela Law LLC announces that shareholder class action lawsuits have been filed against: Apyx Medical Corporation (Nasdaq: APYX) A shareholder.
-
ACCESSWIRE
CLASS ACTION UPDATE for FSNN, APYX and CLDR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / June 13, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...
-
PR Newswire
APYX REMINDER: Hagens Berman Reminds Apyx Medical Corporation (APYX) Investors of Lead Plaintiff Deadline, Encourages Investors to Contact the Firm
SAN FRANCISCO , June 13, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP, with nine offices in eight cities around the country and eighty attorneys, reminds investors in Apyx Medical Corporation ( ...
